Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide constructs derived from the GP120 C5 domain and GP41 transmembrane domain

Peptide constructs derived from the GP120 C5 domain and GP41 transmembrane domain

US Patent 9200065 · Granted Dec 1, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of cannabinoids in the treatment of leukemia2024
Priming of cancer cells with low dose naltrexone2024
Autoimmune therapy2024
Assay to identify anti-cancer agents2024
Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of 2023
Agent that increases the expression of the opioid kappa 1 for the treatment of c2022
Combination for use in the treatment of lung cancer2022
Priming of cancer cells with low dose naltrexone2021
Combination of cannabinoids in the treatment of leukaemia2021
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity i2020
Method for reducing HIV-1 reservoir size using multivalent immunogen and reservo2019
Stabilized HIV-1 peptide constructs comprising the gp120 C5 domain and gp41 hydr2019